skip to primary navigationskip to content

Our Vision

Cardiovascular disease is the number one killer in UK and in most of the Western countries, and is expected to become the most common cause of death globally by 2020. It is already a huge burden to healthcare systems around the world, and improvements in the prevention, diagnosis, and effective treatment will be among the most pressing challenges within our aging populations in this century.

We will transform Cambridge into a world-leading hub for cardiovascular research. The foundation for this is provided through the integration of high quality pre-clinical and clinical research operating in a University-Hospital-Industry partnership. This partnership will be driven by the re-location of the Royal Papworth hospital and AstraZeneca global HQ and R&D facilities to the Cambridge Biomedical Campus, and will be further strengthened by the foundation of a dedicated Cambridge Heart & Lung Research Institute, for which fundraising is ongoing.


Cambridge Cardiovascular logo - transparent

Logo design by Dr Ana-Mishel Spiroski and Dr Sarah Morgan.


We connect cardiovascular researchers in Cambridge.

Please follow us on Twitter for local news about research, events, funding calls, and open positions.

For inquiries about our research or the website, please contact Dr Katja Kivinen.